Publication:
Effect of muscimol on cholinomimetic-induced cardiovascular responses in rats

Simple item page
dc.contributor.authorONAT, FİLİZ
dc.contributor.authorsOnat, F.; Tellioğlu, T.; Aker, R.; Gören, Z.; Iskender, E.; Oktay, S.
dc.date.accessioned2022-03-15T11:14:33Z
dc.date.available2022-03-15T11:14:33Z
dc.date.issued1998
dc.description.abstractBrain acetylcholine and gamma-aminobutyric acid (GABA) are both involved in the regulation of central cardiovascular control. Despite data from anatomical and electrophysiological experiments characterizing the interaction between central GABAergic and cholinergic neurotransmission, the potential significance of this interaction in central cardiovascular regulation remains unknown. The purpose of this study was to determine whether activation of GABA(A) receptors by intracerebroventricular or intrahypothalamic administration of muscimol affects the cholinergic agonist-induced cardiovascular responses. All experiments were performed in conscious, Sprague-Dawley rats instrumented with a guide cannula for drug injection and iliac arterial catheters for direct measurement of mean arterial pressure and heart rate. Administration of a cholinergic agonist, carbachol, either intracerebroventricularly or into the dorsomedial hypothalamic nucleus, produced a significant increase in mean arterial pressure, whereas injection of carbachol into the posterior hypothalamic nucleus caused a slight elevation in blood pressure. Pretreatment with muscimol 10 min before administration of carbachol prevented the carbachol-evoked blood pressure changes. On the other hand, carbachol produced variable changes in heart rate, depending on the site of injection. In [3H]quinuclydinyl benzilate binding experiments, muscimol did not displace the muscarinic radioligand from its binding sites, suggesting that it does not exert any direct antagonistic activity at muscarinic receptors. These results suggest that the dorsomedial hypothalamic nucleus is a potential site of action for microinjected carbachol and that the GABAergic system has an inhibitory influence on cholinergic neurons involved in blood pressure regulation.
dc.identifier.doi10.1016/s0014-2999(98)00754-7
dc.identifier.issn0014-2999
dc.identifier.pubmedPMID: 9874168
dc.identifier.urihttps://hdl.handle.net/11424/249342
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Pharmacology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectFemale
dc.subjectAnimals
dc.subjectRats
dc.subjectBlood Pressure
dc.subjectHeart Rate
dc.subjectRats, Sprague-Dawley
dc.subjectInjections, Intraventricular
dc.subjectDrug Interactions
dc.subjectHypothalamus
dc.subjectCarbachol
dc.subjectCholinergic Agonists
dc.subjectReceptors, Muscarinic
dc.subjectGABA Agonists
dc.subjectMuscimol
dc.subjectReceptors, GABA-A
dc.titleEffect of muscimol on cholinomimetic-induced cardiovascular responses in rats
dc.typearticle
dspace.entity.typePublication
local.avesis.id9b6bcde9-0dae-43d9-a696-d665beccb2c3
local.import.packageSS23
local.import.sourcePubMed
local.indexed.atPUBMED
oaire.citation.endPage181
oaire.citation.startPage173
oaire.citation.titleEuropean Journal of Pharmacology
oaire.citation.volume2-3
relation.isAuthorOfPublicationc359dea3-046f-4397-90d5-62e4bfc31869
relation.isAuthorOfPublication.latestForDiscoveryc359dea3-046f-4397-90d5-62e4bfc31869

Files

Collections

Research Outputs